C44 -Other malignant neoplasms of skin
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C44 – N =420,363
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1982 | 55.8% | 8% | 0.5% | 0.1% | 35.5% | 6,055 |
1983 | 77.6% | 10.8% | 0.5% | 0.2% | 10.8% | 6,243 |
1984 | 80% | 10.8% | 0.6% | 0.2% | 8.4% | 6,100 |
1985 | 80.3% | 10.9% | 0.5% | 0.1% | 8.2% | 6,414 |
1986 | 80% | 11% | 0.7% | 0.2% | 8.2% | 6,507 |
1987 | 83.4% | 11.2% | 0.7% | 0.2% | 4.4% | 6,868 |
1988 | 83.4% | 12% | 0.5% | 0.2% | 3.8% | 6,858 |
1989 | 85.2% | 11.3% | 0.4% | 0.1% | 2.9% | 6,996 |
1990 | 85.7% | 10.6% | 0.5% | 0.3% | 2.9% | 6,784 |
1991 | 84.9% | 10.7% | 0.7% | 0.2% | 3.5% | 7,206 |
1992 | 84.8% | 11.3% | 0.6% | 0.3% | 2.9% | 8,194 |
1993 | 83.3% | 11.8% | 0.5% | 0.3% | 4.1% | 9,180 |
1994 | 86.2% | 9.5% | 0.6% | 0.3% | 3.4% | 9,652 |
1995 | 88.1% | 8.1% | 0.5% | 0.4% | 3% | 10,120 |
1996 | 88.6% | 7.2% | 0.4% | 0.3% | 3.4% | 10,480 |
1997 | 90.1% | 7% | 0.3% | 0.3% | 2.4% | 11,502 |
1998 | 90.2% | 7.2% | 0.5% | 0.1% | 2% | 11,082 |
1999 | 91% | 6.7% | 0.4% | 0.1% | 1.9% | 11,738 |
2000 | 92.3% | 5.9% | 0.3% | 0.1% | 1.3% | 12,150 |
2001 | 91.7% | 6.5% | 0.4% | 0.1% | 1.4% | 12,838 |
2002 | 91.5% | 6.5% | 0.4% | 0.1% | 1.5% | 13,990 |
2003 | 92.3% | 5.8% | 0.3% | 0.1% | 1.5% | 14,617 |
2004 | 92.5% | 6% | 0.4% | 0.1% | 1% | 15,184 |
2005 | 91% | 6.4% | 0.3% | 0.1% | 2.3% | 16,701 |
2006 | 90.7% | 6.8% | 0.4% | 0.1% | 1.9% | 16,623 |
2007 | 91.6% | 5.9% | 0.3% | 0.1% | 2.1% | 18,781 |
2008 | 90.7% | 6.3% | 0.4% | 0.1% | 2.5% | 18,533 |
2009 | 90% | 7% | 0.4% | 0.1% | 2.5% | 19,201 |
2010 | 90.4% | 6.5% | 0.3% | 0.1% | 2.7% | 20,678 |
2011 | 90.4% | 7.1% | 0.5% | 0.2% | 1.7% | 20,843 |
2012 | 90.3% | 7.4% | 0.4% | 0.1% | 1.9% | 22,654 |
2013 | 91.1% | 6.8% | 0.5% | 0.1% | 1.5% | 24,305 |
2014 | 90.1% | 6.2% | 0.4% | 0.1% | 3.2% | 25,286 |